AAT Bioquest

AAT Bioquest, Inc., manufactures superior quality bioanalytical research reagents and kits to scientists engaged in life sciences research, diagnostic R&D and drug discovery. The area of photometric detections, including absorption (color), fluorescence and luminescence technologies and products is AAT Bioquest’s specialty.

Advanced Biotechnologies Inc

Advanced Biotechnologies Inc (ABI) is recognized as The Virology Resource Centre™. ABI specializes in the development and manufacturing of products for the research diagnosis, monitoring, and treatment of infectious diseases.

ABI’s expertise are HIV, HTLV, HSV, VZV, EBV, CMV, HHV-6, HHV-7, HHV-8, RSV, SIV, Rubella, Influenza, Vaccinia, Chlamydia, Neisseria and Toxoplasma.

Biocolor Ltd

Biocolor is a UK based assay development company. They have been producing novel assay since 1993.

Biocolor Assays are high quality products designed to produce novel bench tools, that aid research studies of mammalian cells, tissues and fluids.

Their product line including Apoptosis, Collagen, Elastin, salt soluble protein and sulfated glycosaminoglycans assay kits.

Gene-DireX

GeneDireX established their brand in 2007 and is focused on providing innovative products to the scientific community worldwide. They take advantage of cutting-edge technologies to provide research tools that are high quality, affordable and easy to use. They are the largest DNA and Protein Ladders manufacturer, providing reliable molecular ladders to researchers globally through their channel partners and sales offices.

GenTarget

GenTarget Inc, a Biotech company incorporated in 2008, provides researchers proprietary Bio-reagents and Services in Pre-made Lentiviral particles, mammalian stable cell lines, living cell imaging, high thought-put Cloning and RNAi screening, antibody engineering & expressing, and general reagent fields.  

With their emphasis on product quality and innovation, GenTarget developed many proprietary technologies such as SureTiterTM Lentiviral system; RealtimeChekTM RNAi screening; LightOnTM Live cell imaging and EcoTM instant PCR cloning method.  

Glycosan Biosystems

Glycosan BioSystems manufactures Extracel™ and HyStem™ lines of biocompatible, optimizable hydrogel matrices for general 3-D and stem cell culture. The foundation for both lines is thiol-modified hyaluronic acid which allows a variety of thiol-modified proteins, peptides, or small molecules to be easily crosslinked into the hydrogel. The Extracel line is specifically designed for general and 3-D cell culture. The HyStem line is designed for stem cell culture and transplantation, providing the bridge between cell culture and cell therapy.

Haematologic Technologies

Haematologic Technologies, Inc. (HTI) is a primary manufacturer that specializes in the isolation and characterization of high quality, plasma proteins which are intended for in vitro research use.

HTI’s emphasis is focused on proteins involved in the regulation of blood coagulation and fibrinolysis, as well as the regulation of bone metabolism.

The HTI product line consists of over 150 highly purified and well-characterized proteins including zymogens, enzymes, cofactors, and inhibitors as well as a complementary line of monoclonal and polyclonal antibodies. Additionally, HTI offers a broad line of services, which includes: custom protein purification, protein modification, assay development, contract manufacturing and contract research.

J R Scientific

J R Scientific is a pioneer in the manufacture of classical and custom cell culture media and sera products on a direct basis and under special OEM contracts with other suppliers. J R Scientific, Inc. was the first to provide the industry with large-scale powdered media, low protein serum-free hybridoma and insect cell culture media, and bulk liquid media transfer systems.

Lifeline Cell Technology

Lifeline Cell Technology is a wholly-owned subsidiary of International Stem Cell Corporation (ISCO). They supply pharmaceuticals, academic and government scientists with high-quality human primary cells, stem cells, media and reagents back by over 20 years combined experience in research, development, manufacturing, quality control, marketing and sales for human cell culture products.

Trevigen

Trevigen, Inc. is a rapidly growing biotechnology company focused on the development of technologies pertaining to apoptosis, DNA damage and repair, and genetic variability analysis. Founded in 1992, Trevigen has developed a successful research products business providing new products for the detection and characterization of DNA damage, genetic variations including mutations and polymorphisms, DNA repair, and programmed cell death. Trevigen-brand research products are marketed via the internet, catalog, journal advertising, direct mail, and telemarketing.

Trevigen also has in place supply agreements with major government and university medical research centers. The company is the recipient of several SBIR Phase I grants from the National Institutes of Health, concerning technology development for the analysis of DNA damage and genetic variability. Trevigen has is invented and patented technology for the detection of foreign DNA, DNA mutations and polymorphisms. The technology is called MIDAS (Mutation Identification DNA Analysis System). Trevigen has also developed technology for two approaches for the detection of DNA damage: the CometAssay and FLARE (Fragment Length Analysis by Repair Enzymes)